Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Next Deadline
105 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
October 30, 2025
Extension Available
Until October 30, 2024
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 1, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 31, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 31, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 31, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 24, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 24, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 24, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 2, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 1, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 1, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 1, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 31, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 5, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 5, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 16, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 2, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 1, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 1, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 1, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 10, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 10, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 10, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 17, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 22, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 6, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 016
Printed materials, namely, newsletters, articles and case studies featuring immunoglobulin, immunodeficiency and neurological disorders; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of immunoglobulin, immunodeficiency and neurological disorders; printed educational materials in the field of immunoglobulin, immunodeficiency and neurological disorders
Class 035
Healthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals
Class 041
Healthcare education services, namely, conducting educational programs for patients, caregivers and/or healthcare professionals concerning immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; planning and conducting educational conventions and educational meetings related to immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
Class 044
Providing a website featuring healthcare information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders
Additional Information
Pseudo Mark
INTRAVENOUS IMMUNOGLOBULIN IS OUR MIDDLE NAME
Classification
International Classes
016
035
041
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"IVIG"